Table 2.
Model estimated main effects from logistic regression models of aim 1
Among all participants (n=1241) | |||||
---|---|---|---|---|---|
Aim 1 Outcome: Retained at Week 24 | |||||
Effect | b | SE | p | OR | (95% CI) |
Covariates: | |||||
Age | 0.031 | 0.006 | <.001 | 1.032 | (1.019, 1.044) |
Gender (ref=Female) | 0.000 | 0.137 | 0.999 | 1.000 | (0.764, 1.309) |
Hispanic (ref=No) | −0.353 | 0.176 | 0.044 | 0.702 | (0.498, 0.991) |
Maximum Dose (ref=Low) | 1.383 | 0.141 | <.001 | 3.988 | (3.023, 5.263) |
Predictors: | |||||
Treatment (ref=Buprenorphine) | 1.152 | 0.133 | <.001 | 3.166 | (2.438, 4.111) |
Baseline Pain (ref=No Pain) | 0.109 | 0.128 | 0.398 | 1.115 | (0.866, 1.434) |
Pain Improvement at week 4 (ref=No) | -- | -- | -- | -- | -- |
-- Refers to variables not relevant to the model